AU2003279747A1 - Sh2 domain binding inhibitors - Google Patents

Sh2 domain binding inhibitors

Info

Publication number
AU2003279747A1
AU2003279747A1 AU2003279747A AU2003279747A AU2003279747A1 AU 2003279747 A1 AU2003279747 A1 AU 2003279747A1 AU 2003279747 A AU2003279747 A AU 2003279747A AU 2003279747 A AU2003279747 A AU 2003279747A AU 2003279747 A1 AU2003279747 A1 AU 2003279747A1
Authority
AU
Australia
Prior art keywords
domain binding
binding inhibitors
inhibitors
domain
binding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003279747A
Other versions
AU2003279747A8 (en
Inventor
Terrence R. Burke Jr.
Yang Gao
Zhen-Dan Shi
Johannes H. Voigt
Chang-Qing Wei
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GOVERNMENT OF United States, REPRESENTED BY SECRETARY DEPARTMENT OF HEALTH A
Original Assignee
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services filed Critical US Department of Health and Human Services
Publication of AU2003279747A1 publication Critical patent/AU2003279747A1/en
Publication of AU2003279747A8 publication Critical patent/AU2003279747A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0827—Tripeptides containing heteroatoms different from O, S, or N
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/12—Cyclic peptides with only normal peptide bonds in the ring
    • C07K5/123—Tripeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/12—Cyclic peptides with only normal peptide bonds in the ring
    • C07K5/126—Tetrapeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AU2003279747A 2002-06-28 2003-06-26 Sh2 domain binding inhibitors Abandoned AU2003279747A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US39202802P 2002-06-28 2002-06-28
US60/392,028 2002-06-28
PCT/US2003/019987 WO2004003005A2 (en) 2002-06-28 2003-06-26 Sh2 domain binding inhibitors

Publications (2)

Publication Number Publication Date
AU2003279747A1 true AU2003279747A1 (en) 2004-01-19
AU2003279747A8 AU2003279747A8 (en) 2004-01-19

Family

ID=30000798

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003279747A Abandoned AU2003279747A1 (en) 2002-06-28 2003-06-26 Sh2 domain binding inhibitors

Country Status (2)

Country Link
AU (1) AU2003279747A1 (en)
WO (1) WO2004003005A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050119163A1 (en) 2003-09-18 2005-06-02 The Government Of The United States Of America, As Represented By The Secretary, SH2 domain binding inhibitors
AU2005291957A1 (en) * 2004-09-30 2006-04-13 Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Macrocyclic SH2 domain binding inhibitors
FR2901917B1 (en) 2006-05-31 2008-12-19 Thales Sa CIRCULATOR RADIO FREQUENCY OR HYPERFREQUENCY
WO2008067270A1 (en) * 2006-11-27 2008-06-05 Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Macrocyclic grb2 sh2 domain-binding inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE362767T1 (en) * 1999-10-22 2007-06-15 Us Gov Health & Human Serv INHIBITION OF CELL MOTILITY AND ANGIOGENESIS WITH GRB2 SH2-DOMAIN INHIBITORS
US6977241B2 (en) * 2000-08-22 2005-12-20 The United States Of America As Represented By The Department Of Health & Human Services SH2 domain binding inhibitors

Also Published As

Publication number Publication date
WO2004003005A3 (en) 2007-02-01
AU2003279747A8 (en) 2004-01-19
WO2004003005A2 (en) 2004-01-08

Similar Documents

Publication Publication Date Title
AU2003202263A1 (en) Roh-kinase inhibitors
AU2003249442A1 (en) Kinase inhibitors
AU2003222055A1 (en) Kinase inhibitors
AU2003902828A0 (en) Dpp-iv inhibitor
AU2003902946A0 (en) Dpp-iv inhibitor
AU2003259749A1 (en) 3-pyrrolyl-pyridopyrazoles and 3-pyrrolyl-indazoles as novel kinase inhibitors
AU2003303483A1 (en) Ccr8 inhibitors
AU2001258771A1 (en) -secretase inhibitors
AU2003278088A1 (en) Heteroaryloxy-substituted phenylaminopyrimidines as rho-kinase inhibitors
AU2003265349A1 (en) Pyrrolotriazine kinase inhibitors
AU2003271566A1 (en) Pyrrolopyrazines as kinase inhibitors
AU2003300832A1 (en) NF-KappaB INHIBITORS
AU2003902260A0 (en) Dpp-iv inhibitor
AU2003225523A1 (en) Functional pipelines
AU2003900608A0 (en) Hdac inhibitor
AU2003217341A1 (en) Time domain reflectometry
AU2003299883A1 (en) Ccr8 inhibitors
AU2003249683A1 (en) Nf-:b inhibitors
AU2003238042A1 (en) Cyclooxygenase-2 inhibitors
AU2002952946A0 (en) Dpp-iv inhibitor
AU2003220437A1 (en) Thiopyrimidine and isothiazolopyrimidine kinase inhibitors
AU2003233426A1 (en) Corrosion inhibitor
AU2003230392A1 (en) Beta-secretase inhibitors
AU2003302588A1 (en) Phosphodiesterase 10a inhibitors
AU2002224550A1 (en) Corrosion inhibitors

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase